Position in LEGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$462
+$173 QoQ
Shares Held
16
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#211
of 218 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RAFFA WEALTH MANAGEMENT, LLC holds $112,928 across 35 Biotechnology names. LEGN ranks #24 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
66 | $32,784 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25 | $15,588 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
46 | $8,614 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
60 | $7,354 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
191 | $6,759 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
21 | $6,321 | |
| 7 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 8 | MRNA |
Moderna, Inc.
|
63 | $4,411 |
All Filings in LEGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $462 | 16 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $289 | 16 | Shares | Sole | 2026-07-27 | |
| 2025-12-31 | $347 | 16 | Shares | Sole | 2026-07-27 | |
| 2025-09-30 | $521 | 16 | Shares | Sole | 2026-07-27 | |
| 2025-06-30 | $567 | 16 | Shares | Sole | 2026-07-27 | |
| 2025-03-31 | $542 | 16 | Shares | Sole | 2026-07-27 | |
| 2024-12-31 | $520 | 16 | Shares | Sole | 2026-07-27 | |
| 2024-09-30 | $779 | 16 | Shares | Sole | 2026-07-27 | |
| 2024-06-30 | $708 | 16 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||